Cite Filings / RARE / 0001193125-20-150308
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

Ultragenyx Pharmaceutical Inc. · Filed 2020-05-22 · Acc 0001193125-20-150308

Documents 1

  • SC 13D/A Beneficial Ownership Report , d925199dsc13da.htm

Around this filing

  • 2020-12-10 SC 13D/A Beneficial Ownership Report
  • 2020-05-22 4 Director acquired 600,000 shares (option exercise)
  • 2020-05-22 SC 13D/A Beneficial Ownership Report
  • 2020-05-20 4 Director sold 7,500 shares at $74.65 ($559,875)
  • 2020-05-20 4 CFO & Executive Vice President sold 29,113 shares at an average $73.33 ($2,134,885)
  • 2020-05-19 4 Director sold 1,875 shares at $75.00 ($140,625)
  • 2020-05-19 4 EVP and General Counsel sold 2,722 shares at $74.72 ($203,374)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d925199dsc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…